Antitopoisomerase I antibody in patients with systemic lupus erythematosus/sicca syndrome without a concomitant scleroderma: Two case reports

Clinical Rheumatology

Volumn 22, Issue 1, 2003, Pages 70-72

  Al Attia, H M ^a   D'Souza, M S ^a  

^a MAFRAQ HOSPITAL   (United Arab Emirates)

Author keywords

Anti Scl 70; Antitopoisomerase I antibodies; Scleroderma; SLE

Indexed keywords

ANTIBODY; DNA TOPOISOMERASE; HYDROXYCHLOROQUINE; NIFEDIPINE; PREDNISOLONE; SCL 70 ANTIBODY; ANTINUCLEAR ANTIBODY; NUCLEAR PROTEIN; SCL 70 ANTIGEN, HUMAN;

ADULT; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CASE REPORT; COLLAGEN DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY DISEASE; PRIORITY JOURNAL; SCLERODERMA; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING; IMMUNOLOGY; MIDDLE AGED; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; DNA TOPOISOMERASES, TYPE I, EUKARYOTIC; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NUCLEAR PROTEINS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 0037866884     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-002-0657-2     Document Type: Article

References (19)

1. Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune disease and probes for cell biology. Adv Immunol 44: 93-151
2. Rothfield NF (1992) Autoantibodies in scleroderma. Rheum Dis Clin North Am 18: 483-98
3. Kallenberg CG, Wouda AA, Hoet MH et al. (1988) Development of connective tissue disease in patients with Raynaud's phenomenon: a six year followup with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47: 634-41
4. Satoh M, Kuwana M, Ogasawara T et al. (1994) Association of autoantibodies to topoisomerase 1 and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients. J Immunol 153: 5838-48
5. Ito A, Yasue T (1990) A case of overlap syndrome with SLE and Sjogren's syndrome having anti Scl-70 antibody and later developing PSS. Hifu-Rinsho 32: 1853-6
6. Ogata E, Igarashi A, Soma Y (1993) Significance of anti Scl-70 antibody in the diagnosis of systemic sclerosis: report of two cases. Jpn J Dermatol 103: 931-7
7. Katsumi S, Kobayashi N, Yamamoto Y, Miyagawa S, Shirai T (2000) Development of systemic sclerosis in a patient with systemic lupus erythematosus and topoisomerase I antibody. Br J Dermatol 142: 1030-3
8. Nitta Y, Muramatsu M (2000) Juvenile case of overlap syndrome of systemic lupus erythematosus and polymyositis, later accompanied by systemic sclerosis with the development of anti-Scl70 and Ku antibodies. Pediatr Dermatol 17: 381-3
9. Tan EM, Cohen AS, Fries JF et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7
10. Vitali C, Bombardieri S, Moutsopoulos HM et al. (1993) Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 36: 340-7
11. Gniewek RA, Stites DP, Mchugh TM, Hilton JF, Nakagawa M (1997) Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol 4: 185-8
12. Homburger HA, Cahen YD, Griffith J, Jacob GL (1998) Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods. Arch Pathol Lab Med 122: 993-9
13. Villalta D, Bizzaro N, Tonutti E et al. (1999) Detection of anti-ENA autoantibodies in patients with systemic connective tissue disease.Analytic variability and diagnostic sensitivity of 4 methods. Rec Prog Med 90: 579-84
14. Bizzaro N, Tonutti E, Villalta D et al. (2000) Sensitivity and specificity of immunological methods for the detection of antitopoisomerases (Scl-70) autoantibodies: results of a multicenter study. Clin Chem 46: 1681-5.
15. Henry PA, Atamas SP, Yuovsky VV, Luzina I, Wigley FM, White B (2000) Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma. Arthritis Rheum 43: 2733-42
16. Mukai M, Sagawa A, Atsumi T et al. (1993) Three cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder. J Rheumatol 20: 15947
17. Stojanov L, Satoh M, Dooley MA, Kuwana M, Jennette JC, Reeves WH (1995) Antibodies to topoisomerase I in a patient with systemic lupus erythematosus without features of sclerodermas. Lupus 4: 314-7
18. Al-Mekaimi A, Malaviya AN, Serebour F et al. (1997) Serological characteristics of systemic lupus erythematosus from a hospital-based rheumatology clinic in Kuwait. Lupus 6: 668-74
19. Gussin HA, Ignat GP, Varga J, Teodorescu M (2001) Antitopoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 44: 376-83